86698241 - V

Information

• Trademark
• 86698241

• Source

• Serial Number

  86698241

• Registration Number

  5193786

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 20, 2015
  9 years ago

• Registration Date

  May 02, 2017
  7 years ago

• Transaction Date

  December 26, 2023
  a year ago

• Status Date

  November 17, 2023
  a year ago

• Published for Opposition Date

  February 14, 2017
  8 years ago

• Location Date

  May 02, 2017
  7 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  JOHNSON, DANYTHE ELIZA

• Attorney Docket Number

  38618-388689

  Attorney Name

  Mark Harrison

  Law Office Assigned Location Code

  N20

• Owners

  • Vectura GmbH

Case File Statements

• GS0411: Education services, namely, providing of training, lectures and symposia all relating to pharmaceuticals or drug delivery devices
• DM0000: The mark consists of a stylized letter "V" in the center of a circle with a dark background. The points of the "V" break the border of the circle. There is a shadow underneath the bottom of the circle and along the upper portion of the "V".
• GS0051: Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma
• GS0161: Printed matter, namely, books, magazines, journals, newsletters in the field of pharmaceutical preparations and medical apparatus and drug delivery devices; printed photographs; stationery; plastic materials for packaging, namely, bags and bubble packs; all the aforesaid being goods relating to pharmaceuticals or drug delivery devices
• PM0001: VECTURA
• CC0000: Color is not claimed as a feature of the mark.
• GS0101: Inhalers for medical or therapeutic purposes and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; aerosol dispensers for medical or therapeutic purposes and parts and fittings therefor
• GS0421: Scientific research and technological services, namely, research, design, analysis, and testing, in the field of medicine, pharmaceuticals and drug delivery systems and drug delivery devices; research services in the fields of medicine and drug delivery devices systems and devices; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services; preparation and formulation of pharmaceuticals, namely, consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations

Case File Event Statements

• 11/17/2023 - a year ago

  28 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 5/2/2022 - 2 years ago

  27 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 5/2/2017 - 7 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/14/2017 - 8 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/14/2017 - 8 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/25/2017 - 8 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/9/2017 - 8 years ago

  22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 1/4/2017 - 8 years ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/3/2017 - 8 years ago

  20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/3/2017 - 8 years ago

  19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/3/2017 - 8 years ago

  18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/3/2017 - 8 years ago

  17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/25/2016 - 8 years ago

  16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/25/2016 - 8 years ago

  15 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/25/2016 - 8 years ago

  14 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/4/2016 - 8 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/4/2016 - 8 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/2/2016 - 8 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/5/2015 - 9 years ago

  10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/5/2015 - 9 years ago

  9 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/5/2015 - 9 years ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/29/2015 - 9 years ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 10/19/2015 - 9 years ago

  6 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 10/9/2015 - 9 years ago

  5 - ASSIGNED TO LIE Type: ALIE

• 9/21/2015 - 9 years ago

  4 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 7/25/2015 - 9 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 7/24/2015 - 9 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/23/2015 - 9 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP